Observation on clinical efficacy of Xuebijing in treating brucellosis
Objective To explore the clinical efficacy of Xuebijing in treating brucellosis.Methods 100 patients with brucellosis were randomly divided into a treatment group and a control group according to hospitalization number,with 50 cases in each group.The control group was treated with Western medicine,and the treatment group was treated with Xuebijing on the basis of the control group.The treatment effect,occurrence of adverse reactions,recurrence rate,time to decrease of C-reactive protein,fibrinogen and D-dimer levels before and after treatment were compared between the two groups.Results The total effective rate of the treatment group was 98.00%,which was significantly higher than the control group's 78.00%(P<0.05).The incidence of adverse reactions in the treatment group was 2.00%,which was lower than the control group's 18.00%(P<0.05).After 2 months follow-up,the recurrence rate in the treatment group was 2.00%(1/50),which was lower than the control group's 18.00%(9/50)(P<0.05).The time to decrease of C-reactive protein was(7.54±2.94)d in the treatment group,which was shorter than(7.54±2.94)d in the control group(P<0.05).After treatment,the levels of fibrinogen and D-dimer in the treatment group were(3.01±0.41)g/L and(0.81±0.41)mg/L,which were lower than(3.89±0.55)g/L and(1.76±0.52)mg/L in the control group(P<0.05).Conclusion Xuebijing has remarkable clinical efficacy in treating brucellosis,which can effectively control the disease and reduce the occurrence of adverse reactions,and promote its recovery as soon as possible.So it is recommended to be promoted in clinical practice.
NETL
NSTL
万方数据
